|
1
|
Lee AW, Fee WE Jr, Ng WT and Chan LK:
Nasopharyngeal carcinoma: Salvage of local recurrence. Oral Oncol.
48:768–774. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xu Y, Zhang J, Shi W and Liu Y: Anticancer
effects of 3,3′-diindolylmethane are associated with G1 arrest and
mitochondria-dependent apoptosis in human nasopharyngeal carcinoma
cells. Oncol Lett. 5:655–662. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xiao WW, Huang SM, Han F, Wu SX, Lu LX,
Lin CG, Deng XW, Lu TX, Cui NJ and Zhao C: Local control, survival,
and late toxicities of locally advanced nasopharyngeal carcinoma
treated by simultaneous modulated accelerated radiotherapy combined
with cisplatin concurrent chemotherapy: Long-term results of a
phase 2 study. Cancer. 117:1874–1883. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang J, Liang ZD, Wu TT, Hoque A, Chen H,
Jiang Y, Zhang H and Xu XC: Tumor-suppressive effect of retinoid
receptor-induced gene-1 (RRIG1) in esophageal cancer. Cancer Res.
67:1589–1593. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ammon HP and Wahl MA: Pharmacology of
Curcuma longa. Planta Med. 57:1–7. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
He M, Li Y, Zhang L, Li L, Shen Y, Lin L,
Zheng W, Chen L, Bian X, Ng HK and Tang L: Curcumin suppresses cell
proliferation through inhibition of the Wnt/β-catenin signaling
pathway in medulloblastoma. Oncol Rep. 32:173–180. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Qiao Q, Jiang Y and Li G: Curcumin
enhances the response of non-Hodgkin's lymphoma cells to ionizing
radiation through further induction of cell cycle arrest at the
G2/M phase and inhibition of mTOR phosphorylation. Oncol Rep.
29:380–386. 2013. View Article : Google Scholar
|
|
8
|
Du Q, Hu B, An HM, Shen KP, Xu L, Deng S
and Wei MM: Synergistic anticancer effects of curcumin and
resveratrol in Hepa1-6 hepatocellular carcinoma cells. Oncol Rep.
29:1851–1858. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pan Y, Xiao J, Liang G, Wang M, Wang D,
Wang S and Yang H: A new curcumin analogue exhibits enhanced
antitumor activity in nasopharyngeal carcinoma. Oncol Rep.
30:239–245. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu X, Zhong J, Yan L, Li J, Wang H, Wen Y
and Zhao Y: Curcumin exerts antitumor effects in retinoblastoma
cells by regulating the JNK and p38 MAPK pathways. Int J Mol Med.
38:861–868. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cao A, Li Q, Yin P, Dong Y, Shi H, Wang L,
Ji G, Xie J and Wu D: Curcumin induces apoptosis in human gastric
carcinoma AGS cells and colon carcinoma HT-29 cells through
mitochondrial dysfunction and endoplasmic reticulum stress.
Apoptosis. 18:1391–1402. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zanotto-Filho A, Braganhol E, Klafke K,
Figueiró F, Terra SR, Paludo FJ, Morrone M, Bristot IJ, Battastini
AM, Forcelini CM, et al: Autophagy inhibition improves the efficacy
of curcumin/temozolomide combination therapy in glioblastomas.
Cancer Lett. 358:220–231. 2015. View Article : Google Scholar
|
|
13
|
Bortolozzi R, Viola G, Porcù E, Consolaro
F, Marzano C, Pellei M, Gandin V and Bassoj G: A novel copper(I)
complex induces ER-stress-mediated apoptosis and sensitizes B-acute
lymphoblastic leukemia cells to chemotherapeutic agents.
Oncotarget. 5:5978–5991. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu C, Bailly-Maitre B and Reed JC:
Endoplasmic reticulum stress: Cell life and death decisions. J Clin
Invest. 115:2656–2664. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhong J, Dong X, Xiu P, Wang F, Liu J, Wei
H, Xu Z, Liu F, Li T and Li J: Blocking autophagy enhances
meloxicam lethality to hepatocellular carcinoma by promotion of
endoplasmic reticulum stress. Cell Prolif. 48:691–704. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhong J, Xiu P, Dong X, Wang F, Wei H,
Wang X, Xu Z, Liu F, Li T, Wang Y and Li J: Meloxicam combined with
sorafenib synergistically inhibits tumor growth of human
hepatocellular carcinoma cells via ER stress-related apoptosis.
Oncol Rep. 34:2142–2150. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li W, Wang W, Dong H, Li Y, Li L, Han L,
Han Z, Wang S, Ma D and Wang H: Cisplatin-induced senescence in
ovarian cancer cells is mediated by GRP78. Oncol Rep. 31:2525–2534.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pi L, Li X, Song Q, Shen Y, Lu X and Di B:
Knockdown of glucose-regulated protein 78 abrogates chemoresistance
of hypo-pharyngeal carcinoma cells to cisplatin induced by unfolded
protein in response to severe hypoxia. Oncol Lett. 7:685–692. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yip PY: Phosphatidylinositol
3-kinase-AKT-mammalian target of rapamycin (PI3K-Akt-mTOR)
signaling pathway in non-small cell lung cancer. Transl Lung Cancer
Res. 4:165–176. 2015.PubMed/NCBI
|
|
20
|
Kelber JA, Panopoulos AD, Shani G, Booker
EC, Belmonte JC, Vale WW and Gray PC: Blockade of Cripto binding to
cell surface GRP78 inhibits oncogenic Cripto signaling via
MAPK/PI3K and Smad2/3 pathways. Oncogene. 28:2324–2336. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wey S, Luo B, Tseng CC, Ni M, Zhou H, Fu
Y, Bhojwani D, Carroll WL and Lee AS: Inducible knockout of
GRP78/BiP in the hematopoietic system suppresses Pten-null
leukemogenesis and AKT oncogenic signaling. Blood. 119:817–825.
2012. View Article : Google Scholar :
|
|
22
|
Zhang W, Yang P, Gao F, Yang J and Yao K:
Effects of epigallocatechin gallate on the proliferation and
apoptosis of the nasopharyngeal carcinoma cell line CNE2. Exp Ther
Med. 8:1783–1788. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma J, Wen ZS, Lin P, Wang X and Xie FY:
The results and prognosis of different treatment modalities for
solitary metastatic lung tumor from nasopharyngeal carcinoma: A
retrospective study of 105 cases. Chin J Cancer. 29:787–795. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yin H, Zhou Y, Wen C, Zhou C, Zhang W, Hu
X, Wang L, You C and Shao J: Curcumin sensitizes glioblastoma to
temozolomide by simultaneously generating ROS and disrupting
AKT/mTOR signaling. Oncol Rep. 32:1610–1616. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Peng SF, Lee CY, Hour MJ, Tsai SC, Kuo DH,
Chen FA, Shieh PC and Yang JS: Curcumin-loaded nanoparticles
enhance apoptotic cell death of U2OS human osteosarcoma cells
through the Akt-Bad signaling pathway. Int J Oncol. 44:238–246.
2014. View Article : Google Scholar
|
|
26
|
Wu J, Tang Q, Zhao S, Zheng F, Wu Y, Tang
G and Hahn SS: Extracellular signal-regulated kinase
signaling-mediated induction and interaction of FOXO3a and p53
contribute to the inhibition of nasopharyngeal carcinoma cell
growth by curcumin. Int J Oncol. 45:95–103. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang SJ, Lee SA, Park MG, Kim JS, Yu SK,
Kim CS, Kim JS, Kim SG, Oh JS, Kim HJ, et al: Induction of
apoptosis by diphenyldifluoroketone in osteogenic sarcoma cells is
associated with activation of caspases. Oncol Rep. 31:2286–2292.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schroder M and Kaufman RJ: The mammalian
unfolded protein response. Annu Rev Biochem. 74:739–789. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang K and Kaufman RJ: The unfolded
protein response: A stress signaling pathway critical for health
and disease. Neurology. 66:S102–S109. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li J and Lee AS: Stress induction of
GRP78/BiP and its role in cancer. Curr Mol Med. 6:45–54. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee AS: GRP78 induction in cancer:
Therapeutic and prognostic implications. Cancer Res. 67:3496–3499.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huang KH, Kuo KL, Chen SC, Weng TI, Chuang
YT, Tsai YC, Pu YS, Chiang CK and Liu SH: Down-regulation of
glucose-regulated protein (GRP) 78 potentiates cytotoxic effect of
celecoxib in human urothelial carcinoma cells. PLoS One.
7:e336152012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang J, Yin Y, Hua H, Li M, Luo T, Xu L,
Wang R, Liu D, Zhang Y and Jiang Y: Blockade of GRP78 sensitizes
breast cancer cells to microtubules-interfering agents that induce
the unfolded protein response. J Cell Mol Med. 13:3888–3897. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Singh S, Trevino J, Bora-Singhal N,
Coppola D, Haura E, Altiok S and Chellappan SP: EGFR/Src/Akt
signaling modulates Sox2 expression and self-renewal of stem-like
side-population cells in non-small cell lung cancer. Mol Cancer.
11:732012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Qin J, Ji J, Deng R, Tang J, Yang F, Feng
GK, Chen WD, Wu XQ, Qian XJ, Ding K and Zhu XF: DC120, a novel AKT
inhibitor, preferentially suppresses nasopharyngeal carcinoma
cancer stem-like cells by downregulating Sox2. Oncotarget.
6:6944–6958. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li B, Li J, Xu WW, Guan XY, Qin YR, Zhang
LY, Law S, Tsao SW and Cheung AL: Suppression of esophageal tumor
growth and chemoresistance by directly targeting the PI3K/AKT
pathway. Oncotarget. 5:11576–11587. 2014.PubMed/NCBI
|
|
37
|
Gray MJ, Mhawech-Fauceglia P, Yoo E, Yang
W, Wu E, Lee AS and Lin YG: AKT inhibition mitigates GRP78
(glucose-regulated protein) expression and contribution to
chemoresistance in endometrial cancers. Int J Cancer. 133:21–30.
2013. View Article : Google Scholar : PubMed/NCBI
|
